The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

Stocks•10 May 2026•

1 min read

Danaher (DHR) Valuation Analysis Reveals 18.5% Upside Potential

Key Facts

1A Discounted Cash Flow analysis suggests DHR is undervalued by 18.5%.

2The estimated intrinsic value of the stock is $215.55 compared to its current price of $175.66.

3The current P/E ratio of 33.8x is considered overvalued compared to a calculated fair ratio of 28.4x.

A recent financial analysis of Danaher Corporation suggests that the stock is undervalued by 18.5% based on a Discounted Cash Flow (DCF) model. The estimated intrinsic value stands at $215.55, significantly higher than its current market price of $175.66. This valuation comes as the company strategically pivots its portfolio toward the life sciences sector to drive long-term growth. However, the data presents conflicting signals, as the current P/E ratio of 33.8x exceeds the calculated fair ratio of 28.4x. This discrepancy reflects a mixed outlook between optimistic future cash flows and high current earnings multiples. Investors are closely monitoring whether the life sciences focus can bridge this valuation gap in the coming periods.